Anaptysbio Inc (ANAB)

Finanzdaten der Anaptysbio Inc-Aktie (ANAB)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	76.39%25.56	108.25	76.32	22.26	27.77
Operating Expenses	45.58%60.19	41.35	41.62	48.43	55.31
Operating Income/Loss	151.77%-34.64	66.90	34.70	-26.17	-27.54
Nonoperating Income/Loss	5.82%-18.21	-17.21	-19.59	-12.42	-11.75
Income/Loss From Continuing Operations Before Tax	206.34%-52.84	49.70	15.11	-38.59	-39.29
Income Tax Expense/Benefit, Current	0.04	-	-	-	0.04
Income Tax Expense/Benefit	50.62%0.04	0.08	-	0.04	0.04
	206.59%-52.88	49.61	15.11	-38.63	-39.33
Attributable To Parent	206.59%-52.88	49.61	15.11	-38.63	-39.33
Basic Average Shares	8,874%28.69	-0.33	27.83	28.81	30.64
Diluted Average Shares	8,874%28.69	-0.33	29.02	28.81	30.64
Basic Earnings Per Share	208.24%-1.84	1.70	0.54	-1.34	-1.28
Diluted Earnings Per Share	208.24%-1.84	1.70	0.52	-1.34	-1.28